{"symbol":"ABBV","fiscalQuarter":"Q1-2023","reportDate":"2023-04-27","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2023","postBrief":{"headline":"AbbVie Beats on EPS, Stock Down 7.99%","keyNumbers":[{"metric":"EPS","actual":"$2.46","expected":"N/A","surprise":"+0.78%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No forward guidance data is available.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a positive surprise on EPS, but the stock reacted negatively, dropping nearly 8%. Investors may be concerned about the lack of revenue details and future guidance, which could indicate uncertainty about the company's performance going forward.","metaDescription":"AbbVie Inc. (ABBV) Q1 2023 earnings: EPS beat by 0.78%. Stock down 7.99%. Full breakdown."}}